Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Definitive Healthcare (DH) EBITDA (2020 - 2025)

Definitive Healthcare (DH) has disclosed EBITDA for 6 consecutive years, with -$26.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBITDA rose 73.26% year-over-year to -$26.6 million, compared with a TTM value of -$224.3 million through Dec 2025, up 68.45%, and an annual FY2025 reading of -$224.3 million, up 68.45% over the prior year.
  • EBITDA was -$26.6 million for Q4 2025 at Definitive Healthcare, down from -$8.7 million in the prior quarter.
  • Across five years, EBITDA topped out at -$2.6 million in Q1 2021 and bottomed at -$369.6 million in Q2 2024.
  • Average EBITDA over 5 years is -$66.9 million, with a median of -$12.0 million recorded in 2022.
  • The sharpest move saw EBITDA crashed 2962.22% in 2024, then skyrocketed 98.87% in 2025.
  • Year by year, EBITDA stood at -$14.5 million in 2021, then increased by 27.38% to -$10.5 million in 2022, then increased by 4.34% to -$10.1 million in 2023, then plummeted by 887.73% to -$99.6 million in 2024, then surged by 73.26% to -$26.6 million in 2025.
  • Business Quant data shows EBITDA for DH at -$26.6 million in Q4 2025, -$8.7 million in Q3 2025, and -$4.2 million in Q2 2025.